contraception Flashcards
(48 cards)
Perfect Use vs Typical Use
COC 0.3/8.7
POP 0.5/3
Mirena 0.1/0.1 - best
Cu IUD 0.6/1
Implanon 0.05/1
DMPA 0.3/0.3
Withdrawal 4/18.4
Condom Male 2/17.4
Lap sterilization
unipolar/bipolar coag
fislhie clip (yung parang ipit lang na walang teeth –> best, titanium)
silastic/yoon (yung ring na rubber)
hulka (yung may teeth na plastic)
types of BTL
Pomeroy
Irving
Uchida
best vasectomy reversal
if within 3 yrs from procedure
predictors of success reversal BTL
age at reversal
4cm remaining tube
OCP VTE risk
low dose OCP regardless of progestin has inc vte risk in the first to second yr
risk inc with age and weight
estrogen inc clotting factors while progestin no effect
OCP MI/Stroke
no inc risk regardless of age if nonsmoker and EE<50mcg
OCP and cancers
(-) endom Ca
(-) ovarian Ca
(-) colorectal
+ cervical – inc CIS
+ liver Ca – hepatocellular ca
+ breast CA – uncertain
(-) = protective
+ = inc risk
DMPA special indication
sickle cell disease
seizure disorder
DMPA disadvantages
must ensure PT negative or else IUGR associated neonatal death
9 month delay to ovulation
PID highest in IUD
20 days after insertion
can be inserted post partum
but if not inserted due to infection, 4-5weeks post partum
DMPA backup
if not started during menses, backup x 7 days
can be late for up to 2 weeks
Diaphragm/cap/sponge/female condom
when to insert
6/6/24/8
Diaphragm/cap/sponge/female condom
duration post coitus
6/8/6/6
Diaphragm/cap/sponge/female condom
max
24/48/30/8
1st generation estrane
norethisterone, lynestrenol, norethyndronel, ethynodiol diacetate
1st generation pregnane
MPA, megace
2nd generation
levonorgestrel, norgestrel
3rd generation
gestodene, norgestimate, desogestrel, etonogestrel, norelgestromin
4th generation estrane
dienogest
drosperinone
4th generation pregnane
nomegestrol acetate
nesterone
trimgestrone
19-nortestosterone hormones
androgenic, progestational, estrogenic
inc insulin resistance, dec glucose tolerance
norethindrone
norethyndronel
ethyndronel diacetate
lynestrenol
extended regimen
24 day products to:
decrease ovarian activity
dec breakthrough bleeding
greatest incidence of breakthrough bleeding
first 3 months 10-30%